Literature DB >> 20880044

The unintended consequence of diabetes mellitus pay-for-performance (P4P) program in Taiwan: are patients with more comorbidities or more severe conditions likely to be excluded from the P4P program?

Tsung-Tai Chen1, Kuo-Piao Chung, I-Chin Lin, Mei-Shu Lai.   

Abstract

OBJECTIVE: Taiwan has instituted a pay-for-performance (P4P) program for diabetes mellitus (DM) patients that rewards doctors based in part on outcomes for their DM patients. Doctors are permitted to choose which of their DM patients are included in the P4P program. We test whether seriously ill DM patients are disproportionately excluded from the P4P program. DATA SOURCE/STUDY
SETTING: This study utilizes data from the National Health Insurance (NHI) database in Taiwan for the period of January 2007 to December 2007. Our sample includes 146,481 DM-P4P patients (16.56 percent of the total) and 737,971 non-DM-P4P patients. DATA COLLECTION/EXTRACTION
METHODS: We use logistic and multilevel models to estimate the effects of patient and hospital characteristics on P4P selection. PRINCIPAL
FINDINGS: The results show that older patients and patients with more comorbidities or more severe conditions are prone to be excluded from P4P programs.
CONCLUSIONS: We found that DM patients are disproportionately excluded from P4P programs. Our results point to the importance of mandated participation and risk adjustment measures in P4P programs. © Health Research and Educational Trust.

Entities:  

Mesh:

Year:  2010        PMID: 20880044      PMCID: PMC3034261          DOI: 10.1111/j.1475-6773.2010.01182.x

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  34 in total

1.  Paying physicians for high-quality care.

Authors:  Arnold M Epstein; Thomas H Lee; Mary Beth Hamel
Journal:  N Engl J Med       Date:  2004-01-22       Impact factor: 91.245

2.  Using multilevel analysis in patient and organizational outcomes research.

Authors:  Sung-Hyun Cho
Journal:  Nurs Res       Date:  2003 Jan-Feb       Impact factor: 2.381

3.  Physician clinical performance assessment: prospects and barriers.

Authors:  Bruce E Landon; Sharon-Lise T Normand; David Blumenthal; Jennifer Daley
Journal:  JAMA       Date:  2003-09-03       Impact factor: 56.272

4.  Towards a scientific workflow methodology for primary care database studies.

Authors:  Vasa Curcin; Alex Bottle; Mariam Molokhia; Christopher Millett; Azeem Majeed
Journal:  Stat Methods Med Res       Date:  2010-05-04       Impact factor: 3.021

5.  Accuracy of diabetes diagnosis in health insurance claims data in Taiwan.

Authors:  Cheng-Ching Lin; Mei-Shu Lai; Ci-Yong Syu; Shuan-Chuan Chang; Fen-Yu Tseng
Journal:  J Formos Med Assoc       Date:  2005-03       Impact factor: 3.282

6.  Public health application comparing multilevel analysis with logistic regression: immunization coverage among long-term care facility residents.

Authors:  Barbara H Bardenheier; Abigail Shefer; Lawrence Barker; Carla A Winston; C Kristina Sionean
Journal:  Ann Epidemiol       Date:  2005-11       Impact factor: 3.797

7.  Use of a disease severity index for evaluation of healthcare costs and management of comorbidities of patients with diabetes mellitus.

Authors:  James L Rosenzweig; Katie Weinger; Laurinda Poirier-Solomon; Mary Rushton
Journal:  Am J Manag Care       Date:  2002-11       Impact factor: 2.229

8.  Developing a prediction rule from automated clinical databases to identify high-risk patients in a large population with diabetes.

Authors:  J V Selby; A J Karter; L M Ackerson; A Ferrara; J Liu
Journal:  Diabetes Care       Date:  2001-09       Impact factor: 19.112

9.  The unintended consequences of publicly reporting quality information.

Authors:  Rachel M Werner; David A Asch
Journal:  JAMA       Date:  2005-03-09       Impact factor: 56.272

10.  Selection incentives in a performance-based contracting system.

Authors:  Yujing Shen
Journal:  Health Serv Res       Date:  2003-04       Impact factor: 3.402

View more
  22 in total

1.  Effects of Changes in Diabetes Pay-for-Performance Incentive Designs on Patient Risk Selection.

Authors:  Hui-Min Hsieh; Shu-Ling Tsai; Lih-Wen Mau; Herng-Chia Chiu
Journal:  Health Serv Res       Date:  2015-07-07       Impact factor: 3.402

2.  Effect of blood pressure trajectory and variability on new-onset chronic kidney disease in patients with type 2 diabetes.

Authors:  Cheng-Chieh Lin; Chia-Ing Li; Chiu-Shong Liu; Chih-Hsueh Lin; Mu-Cyun Wang; Shing-Yu Yang; Tsai-Chung Li
Journal:  Hypertens Res       Date:  2022-03-03       Impact factor: 3.872

3.  Assessing Taiwan's pay-for-performance program for diabetes care: a cost-benefit net value approach.

Authors:  Jui-Fen Rachel Lu; Ying Isabel Chen; Karen Eggleston; Chih-Hung Chen; Brian Chen
Journal:  Eur J Health Econ       Date:  2022-08-22

4.  Is a diabetes pay-for-performance program cost-effective under the National Health Insurance in Taiwan?

Authors:  Elise Chia-Hui Tan; Raoh-Fang Pwu; Duan-Rung Chen; Ming-Chin Yang
Journal:  Qual Life Res       Date:  2013-08-23       Impact factor: 4.147

5.  Cost-Effectiveness of a Diabetes Pay-For-Performance Program in Diabetes Patients with Multiple Chronic Conditions.

Authors:  Hui-Min Hsieh; Song-Mao Gu; Shyi-Jang Shin; Hao-Yun Kao; Yi-Chieh Lin; Herng-Chia Chiu
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

6.  Association between the Value-Based Purchasing pay for performance program and patient mortality in US hospitals: observational study.

Authors:  Jose F Figueroa; Yusuke Tsugawa; Jie Zheng; E John Orav; Ashish K Jha
Journal:  BMJ       Date:  2016-05-09

7.  Comparing the mortality risks of nursing professionals with diabetes and general patients with diabetes: a nationwide matched cohort study.

Authors:  Hsiu-Ling Huang; Chuan-Yu Kung; Cheng-Chin Pan; Pei-Tseng Kung; Shun-Mu Wang; Wen-Yu Chou; Wen-Chen Tsai
Journal:  BMC Public Health       Date:  2016-10-06       Impact factor: 3.295

8.  Pay-for-performance: impact on diabetes.

Authors:  Tim Doran; Evangelos Kontopantelis
Journal:  Curr Diab Rep       Date:  2013-04       Impact factor: 4.810

9.  A non-experimental study of oral anticoagulation therapy initiation before and after national patient safety goals.

Authors:  Christopher A Beadles; Kristen Hassmiller Lich; Anthony J Viera; Sandra B Greene; M Alan Brookhart; Morris Weinberger
Journal:  BMJ Open       Date:  2014-02-12       Impact factor: 2.692

10.  A competing risk analysis of sequential complication development in Asian type 2 diabetes mellitus patients.

Authors:  Li-Jen Cheng; Jeng-Huei Chen; Ming-Yen Lin; Li-Chia Chen; Chun-Huan Lao; Hsing Luh; Shang-Jyh Hwang
Journal:  Sci Rep       Date:  2015-10-28       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.